International Journal of Drug Policy
Volume 13, Issue 3 , Pages 165-174, September 2002

HIV risk behaviour among participants of syringe exchange programmes in central/eastern Europe and Russia

  • Don C Des Jarlais

      Affiliations

    • Baron Edmond de Rothschild Chemical Dependency Institute/Beth Israel Medical Center, 1st Avenue & E. 16th Street, New York, NY 10003, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-212-387-3803; fax: +1-212-387-3897
  • ,
  • Jean-Paul Grund

      Affiliations

    • Baron Edmond de Rothschild Chemical Dependency Institute/Beth Israel Medical Center, 1st Avenue & E. 16th Street, New York, NY 10003, USA
  • ,
  • Catherine Zadoretzky

      Affiliations

    • Baron Edmond de Rothschild Chemical Dependency Institute/Beth Israel Medical Center, 1st Avenue & E. 16th Street, New York, NY 10003, USA
  • ,
  • Judith Milliken

      Affiliations

    • Baron Edmond de Rothschild Chemical Dependency Institute/Beth Israel Medical Center, 1st Avenue & E. 16th Street, New York, NY 10003, USA
  • ,
  • Patricia Friedmann

      Affiliations

    • Baron Edmond de Rothschild Chemical Dependency Institute/Beth Israel Medical Center, 1st Avenue & E. 16th Street, New York, NY 10003, USA
  • ,
  • Stephen Titus

      Affiliations

    • Baron Edmond de Rothschild Chemical Dependency Institute/Beth Israel Medical Center, 1st Avenue & E. 16th Street, New York, NY 10003, USA
    • Columbia University, New York, NY, USA
  • ,
  • Theresa Perlis

      Affiliations

    • National Development and Research Institutes, New York, NY, USA
  • ,
  • Valentina Bodrova

      Affiliations

    • Research Center for Public Opinion and Market Research, Moscow, Russia
  • ,
  • Elena Zemlianova

      Affiliations

    • Ministry of Health of Russia, Moscow, Russia

Abstract 

Objective: To assess HIV risk behaviour among participants in syringe exchanges in five Central/Eastern European cities: Prague (Czech Republic), Budapest (Hungary), Skopje (Former Yugoslavian Republic of Macedonia), Krakow (Poland) and Poltava (Ukraine), and five Russian cities: Nizhniy Novgorod, Pskov, Rostov-Na-Donu, St. Petersburg, and Volgograd. Design: Cross-sectional survey with questions on injection risk behaviours for the 30 days prior to first use of the syringe exchange programme and for the 30 days prior to interview (while using the syringe exchange programme). Methods: Respondents were recruited from participants of the syringe exchanges. Structured questionnaires covering drug use and HIV risk behaviour were administered by trained interviewers. Results: 1671 respondents were interviewed across the ten programmes. Participants in the programmes tended to be young and relatively recent initiates into drug injection. Relatively low percentages of participants reported receptive syringe sharing (‘injecting with needles and syringes used by others’) in the past 30 days, from 1 to 29% across the ten programmes. These represented statistically significant reductions from the percentages of respondents reporting receptive syringe sharing in the 30 days prior to first use of the syringe exchange—from 7 to 47%. Conclusions: IDUs participating in the exchanges appear to be responding very positively in reducing sharing of needles and syringes. Syringe exchange and other HIV prevention programmes for injecting drug users (IDUs) in this geographic region should be expanded rapidly.

Keywords:  HIV, Risk behaviour, Syringe exchange programmes, Eastern Europe, Russia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(02)00070-1

doi:10.1016/S0955-3959(02)00070-1

International Journal of Drug Policy
Volume 13, Issue 3 , Pages 165-174, September 2002